Literature DB >> 12611278

Vehicle effects on in vitro skin permeation of thiocolchicoside.

F Bonina1, C Puglia, D Trombetta, M C Dragani, M M Gentile, G Clavenna.   

Abstract

Thiocolchicoside, a semi-synthetic derivative of colchicoside, is used in topical formulations for its anti-inflammatory and muscle-relaxant properties. The objective of this study was to evaluate the effect of a (propylene glycol diperlagonate) DPPG and (propylene glycol) PG mixture present in an innovative foam formulation (Miotens) on the flux of thiocolchicoside through excised human skin. Furthermore, the in vitro permeation behaviour of this new formulation (Miotens foam) was compared to another commercial product (Muscoril ointment) and to a control gel formulation (thiogel), both enhancer free. The best permeation profile was obtained from the foam formulation (Miotens) which was able to increase the thiocolchicoside flux about three fold compared to control formulation (thiogel) and about two fold compared to the commercial formulation Muscoril ointment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12611278

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  2 in total

1.  Penetration and distribution of thiocolchicoside through human skin: comparison between a commercial foam (Miotens) and a drug solution.

Authors:  Carola Aguzzi; Silvia Rossi; Michela Bagnasco; Luigi Lanata; Giuseppina Sandri; Fosca Bona; Franca Ferrari; Maria Cristina Bonferoni; Carla Caramella
Journal:  AAPS PharmSciTech       Date:  2008-12-03       Impact factor: 3.246

2.  The effect of topical thiocolchicoside in preventing and reducing the increase of muscle tone, stiffness, and soreness: A real-life study on top-level road cyclists during stage competition.

Authors:  Marco Gervasi; Davide Sisti; Piero Benelli; Eneko Fernández-Peña; Cinzia Calcabrini; Marco B L Rocchi; Luigi Lanata; Michela Bagnasco; Andrea Tonti; Stocchi Vilberto; Piero Sestili
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.